Gmt Capital Corp Ocugen, Inc. Transaction History
Gmt Capital Corp
- $2.21 Billion
- Q3 2025
A detailed history of Gmt Capital Corp transactions in Ocugen, Inc. stock. As of the latest transaction made, Gmt Capital Corp holds 4,153,798 shares of OCGN stock, worth $4.94 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
4,153,798
Previous 4,153,798
-0.0%
Holding current value
$4.94 Million
Previous $4.03 Million
68.03%
% of portfolio
0.31%
Previous 0.17%
Shares
4 transactions
Others Institutions Holding OCGN
# of Institutions
108Shares Held
60.5MCall Options Held
531KPut Options Held
433K-
Black Rock Inc. New York, NY17.9MShares$21.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$18.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.16MShares$4.95 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.68MShares$4.38 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.57MShares$1.87 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $258M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...